Tuesday, August 4, 2009

Warner Chilcott Announces Receipt of Paragraph IV Certification Notices

Warner Chilcott Limited announced today that it has received two Paragraph IV Certification Notices from Lupin Ltd. The Paragraph IV Certification Notices advise the Company of the filing of ANDAs by Lupin for generic versions of the Company's oral contraceptives, LOESTRIN 24 FE and FEMCON FE.

the details can be read here.

No comments: